Significance of Regional Ventriculo-arterial Coupling in Patients With Chronic Heart Failure

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT01156207

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01156207
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
Taiwan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01156207. Randomized; triple masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2013-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Significance of Regional Ventriculo-arterial Coupling in Patients With Chronic Heart Failure
Acronym
VACHF
Condition
Heart Failure
Intervention (Drug)
Aliskiren
Lead sponsor
Taipei Veterans General Hospital, Taiwan (class: other government)
Collaborator
National Science and Technology Council, Taiwan (class: other government)

Record details

Record id
cardio:ct-nct01156207
Content hash
9e3f26b6320989af68f968332c6d517c419dcdc4151b767027ababb7d5f1ed4a